Neuromodulation device developer Neuros Medical has raised $20m in a series AA round backed by existing investor Boston Scientific .
US-based neuromodulation system developer Neuros Medical secured $20m in series AA financing from investors including medical device producer Boston Scientific yesterday.
The round was led by venture capital firm US Venture Partners (USVP) and included healthcare-focused investment firm Aperture Venture Partners, academic research commercialisation VC firm Osage University Partners and accelerator JumpStart.
Neuros is developing products based on its core technology, an implantable generator called the Altius High Frequency Electrical Nerve Block.
Altius uses a rechargeable battery, cuff electrode and…